The healthcare world is witnessing a remarkable shift in glucose treatment with the emergence of GLP-1 transdermal devices. These systems offer a potentially more comfortable alternative to injections of GLP-1 drugs, reducing the need for daily needle pokes. The technology administers the drug directly through the surface, possibly enhancing indivi